Novo Nordisk shares plunge after Alzheimer's drug trial fails to hit key target (2025-11-24)
Shares of Novo Nordisk plunged after the Danish pharmaceutical company said a highly anticipated trial for Alzheimer's disease failed to meet its main goal.